SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-04-010295
Filing Date
2004-02-17
Accepted
2004-02-17 19:14:49
Documents
1
Period of Report
2004-02-12

Document Format Files

Seq Description Document Type Size
1 rrd33570.html 4  
1 rrd33570.xml 4 8209
  Complete submission text file 0001181431-04-010295.txt   10010
Mailing Address 100 BEAVER STREET WALTHAM MA 02453
Business Address 1OO BEAVER ST WALTHAM MA 02453 7813982300
GENOME THERAPEUTICS CORP (Issuer) CIK: 0000356830 (see all company filings)

IRS No.: 042297484 | State of Incorp.: MA | Fiscal Year End: 0831
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O GENESOFT PHARMACEUTICALS INC 7300 SHORELINE COURT S SAN FRANCISCO CA 94080
Business Address
SINGER DAVID B (Reporting) CIK: 0001240366 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-10824 | Film No.: 04611270